We are live on ! Find out more
TDC

Thompson Davis & Co Portfolio holdings

AUM $150M
1-Year Est. Return 32.35%
This Fund
S&P 500
This Quarter Est. Return
+15.74%
1 Year Est. Return
+32.35%
3 Year Est. Return
+199.51%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$45.9M
AUM Growth
+$3.85M
Cap. Flow
-$689K
Cap. Flow %
-1.5%
Top 10 Hldgs %
19.46%
Holding
843
New
156
Increased
138
Reduced
151
Closed
116

Top Buys

Rank Stock Value
1
GMED icon
Globus Medical
GMED
+$350K
2
DIS icon
Walt Disney
DIS
+$321K
3
WMGI
Wright Medical Group Inc
WMGI
+$294K
4
T icon
AT&T
T
+$265K
5
ADT icon
ADT
ADT
+$263K

Top Sells

Rank Stock Value
1
CDNA icon
CareDx
CDNA
+$546K
2
AKTS
Akoustis Technologies Inc
AKTS
+$473K
3
VZ icon
Verizon
VZ
+$307K
4
VICR icon
Vicor
VICR
+$282K
5
KRE icon
State Street SPDR S&P Regional Banking ETF
KRE
+$265K

Sector Composition

Rank Sector Weight
1 Technology 18.7%
2 Healthcare 13.98%
3 Financials 8.19%
4 Industrials 8.17%
5 Consumer Discretionary 7.95%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CHK
701
DELISTED
Chesapeake Energy Corporation
CHK
$1K ﹤0.01%
1
– –
ARQL
702
DELISTED
Arqule Inc
ARQL
$1K ﹤0.01%
+125
New +$711
RIBT
703
DELISTED
RiceBran Technologies
RIBT
$1K ﹤0.01%
+50
New +$1.4K
ACTG icon
704
Acacia Research
ACTG
$450M
– –
-500
Closed -$2K
AGCO icon
705
AGCO
AGCO
$8.78B
– –
-200
Closed -$12K
AMAT icon
706
Applied Materials
AMAT
$426B
– –
-1,000
Closed -$46K
AOS icon
707
A.O. Smith
AOS
$8.38B
– –
-1,441
Closed -$85K
APLS
708
DELISTED
Apellis Pharmaceuticals
APLS
– –
-125
Closed -$3K
ASIX icon
709
AdvanSix
ASIX
$567M
$0 ﹤0.01%
5
– –
ATOM icon
710
Atomera
ATOM
$201M
– –
-2,300
Closed -$14K
BCLI
711
DELISTED
BRAINSTORM CELL THERAPUTC
BCLI
– –
-13
Closed -$1K
BNY
712
Bank of New York Mellon
BNY
$108B
– –
-318
Closed -$17K
BOX icon
713
Box
BOX
$4.02B
– –
-1,750
Closed -$44K
CALX icon
714
Calix
CALX
$2.27B
$0 ﹤0.01%
2
– –
CANF
715
Can-Fite BioPharma American Depositary Shares
CANF
$6.83M
– –
-3
Closed -$9K
CDE icon
716
Coeur Mining
CDE
$15.6B
$0 ﹤0.01%
10
– –
CHDN icon
717
Churchill Downs
CHDN
$6.03B
– –
-1,974
Closed -$98K
MBAI
718
Check-Cap
MBAI
$8.5M
– –
-25
Closed -$2K
CLNE icon
719
Clean Energy Fuels
CLNE
$447M
– –
-3,500
Closed -$13K
CMCO icon
720
Columbus McKinnon
CMCO
$465M
– –
-125
Closed -$5K
COGT icon
721
Cogent Biosciences
COGT
$6.79B
– –
-217
Closed -$12K
CRMD icon
722
CorMedix
CRMD
$617M
– –
-400
Closed –
CTLP
723
DELISTED
Cantaloupe
CTLP
– –
-250
Closed -$4K
CTRA
724
DELISTED
Coterra Energy
CTRA
– –
-200
Closed -$5K
CWH icon
725
Camping World
CWH
$363M
– –
-1,125
Closed -$28K
27 28
29
30 31

Similar funds

PAYA
Phil A. Younker & Associates Fairbanks, Alaska $150M AUM 9.85% 1-Year Est. Return
PCMNC
Piedmont Capital Management (North Carolina) Greensboro, North Carolina $150M AUM
LA
Lakeside Advisors Seattle, Washington $150M AUM 14.73% 1-Year Est. Return
MPW
Magnolia Private Wealth Philadelphia, Pennsylvania $150M AUM 18.29% 1-Year Est. Return
GWA
Genesis Wealth Advisors Braintree, Massachusetts $150M AUM 15.35% 1-Year Est. Return
GA
Gordian Advisors Tucson, Arizona $150M AUM 15.35% 1-Year Est. Return
RPA
Redwood Park Advisors Redwood City, California $150M AUM 11.34% 1-Year Est. Return
E
Evansbrook Bolingbrook, Illinois $150M AUM

Thompson Davis & Co's Q3 2018 Portfolio in Review

As of Q3 2018, Thompson Davis & Co held 843 positions worth $45.9M, up 9.2% from $42M the previous quarter. Its ten largest holdings account for 19% of the portfolio.

Thompson Davis & Co's Q3 2018 filing shows 156 new, 138 increased, 151 reduced and 116 closed positions. Its largest new stake was Globus Medical: 6,660 shares worth $378K. The largest sale was CareDx, an estimated $546K.

By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 18% a quarter earlier, followed by Healthcare and Financials.

  • Thompson Davis & Co's largest Q3 2018 buy was Globus Medical: 6,660 shares worth $378K.
  • Thompson Davis & Co added most to Walt Disney in Q3 2018, an estimated $321K increase.
  • Thompson Davis & Co's biggest Q3 2018 reduction was CareDx, cutting an estimated $546K.
  • Thompson Davis & Co fully exited Vicor in Q3 2018, selling an estimated $282K.
  • Thompson Davis & Co's ten largest holdings make up 19% of its $45.9M portfolio in Q3 2018.
  • Thompson Davis & Co opened 156 new positions and closed 116 in Q3 2018.
  • Thompson Davis & Co's portfolio value rose 9.2% quarter-over-quarter to $45.9M.

Based on Thompson Davis & Co's 13F filing for Q3 2018, filed 14 Nov 2018.